Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shanghai Bio-Heart Biological Technology Co., Ltd. announced a major transaction involving a capital injection of RMB155.6 million into its subsidiary, Zhejiang Bioheart, by an investor, reducing the company’s stake from 100% to 54.6792%. This transaction, subject to shareholder approval, could significantly impact the company’s structure and financial standing. Additionally, proposed amendments to the company’s Articles of Association aim to refine its business scope and operational regulations.
For further insights into HK:2185 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue